Publication | Closed Access

Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial

Hematological MalignancyOncologyMarrow TransplantationTransplantationLong-term Follow-upStem Cell TransplantationHematologyMyeloid NeoplasiaSorafenib MaintenanceRadiation OncologyMedicineCell TransplantationHealth Sciences